Pacific Biosciences of Ca... (PACB)
1.31
-0.14 (-9.66%)
At close: Mar 03, 2025, 3:59 PM
1.36
3.42%
Pre-market: Mar 04, 2025, 07:03 AM EST
Pacific Biosciences of California Inc. Revenue Breakdown
| Quarter | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumable Revenue | 18.51M | 15.98M | 16.87M | 43.66M | 13.95M | 22.77M | 27.51M | 30.18M | 28.24M | 37.19M | 12.25M | 10.36M | 23.63M | 8.02M | 4.82M | 8.27M | 24.55M | 6.9M | 8.59M | 7.83M | 9.91M | 8.85M | 9.96M | 9.14M |
| Consumable Revenue Growth | +15.79% | -5.24% | -61.36% | +212.85% | -38.72% | -17.22% | -8.84% | +6.84% | -24.06% | +203.58% | +18.21% | -56.13% | +194.52% | +66.36% | -41.69% | -66.32% | +255.76% | -19.62% | +9.60% | -20.96% | +11.94% | -11.10% | +9.00% | n/a |
| Instrument Revenue | 16.79M | 19.02M | 34.69M | 13.73M | 20.7M | 4.58M | 4.8M | 5.29M | 4.93M | 45.15M | 14.28M | 14.94M | 3.51M | 7.73M | 8.93M | 4.02M | 3.38M | 11.58M | 12.66M | 5.62M | 6.53M | 6.3M | 8.53M | 7.14M |
| Instrument Revenue Growth | -11.76% | -45.16% | +152.65% | -33.66% | +351.77% | -4.58% | -9.26% | +7.36% | -89.08% | +216.11% | -4.40% | +325.61% | -54.57% | -13.51% | +122.02% | +19.09% | -70.83% | -8.54% | +125.22% | -13.85% | +3.67% | -26.15% | +19.33% | n/a |
| Product Revenue | 35.3M | 35.01M | 51.56M | 29.92M | 34.65M | n/a | 16.07M | 14.56M | 12.69M | 30.5M | 26.53M | 25.3M | n/a | 15.75M | 13.76M | 12.29M | n/a | 18.48M | 21.25M | 13.46M | 16.44M | 15.15M | 18.48M | 16.28M |
| Product Revenue Growth | +0.82% | -32.10% | +72.32% | -13.65% | n/a | n/a | +10.38% | +14.67% | -58.38% | +14.96% | +4.86% | n/a | n/a | +14.49% | +11.90% | n/a | n/a | -13.02% | +57.91% | -18.13% | +8.50% | -18.04% | +13.53% | n/a |
| Service And Other Revenue | 4.67M | 3.8M | 4.13M | 3.92M | 4.25M | n/a | 11.44M | 15.62M | 15.55M | 4.38M | 4.08M | 3.69M | n/a | 3.33M | 3.32M | 3.31M | n/a | 3.43M | 3.37M | 2.97M | 3.09M | 3.01M | 3.09M | 3.08M |
| Service And Other Revenue Growth | +22.89% | -7.94% | +5.39% | -7.72% | n/a | n/a | -26.74% | +0.44% | +254.62% | +7.55% | +10.37% | n/a | n/a | +0.36% | +0.48% | n/a | n/a | +1.78% | +13.58% | -3.89% | +2.59% | -2.68% | +0.42% | n/a |
Revenue by Geography
| Quarter | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia Pacific Revenue | 36.15M | 35.72M | 22.55M | 26.61M | 29.07M | 39.7M | 20M | 9M | 10.1M | 9.2M | 6.6M |
| Asia Pacific Revenue Growth | +1.19% | +58.40% | -15.25% | -8.46% | -26.78% | +98.50% | +122.22% | -10.89% | +9.78% | +39.39% | n/a |
| Europe Revenue | 22.6M | 30.27M | 19.07M | 19.6M | 13.96M | 13.2M | 50.8M | 68.8M | n/a | n/a | n/a |
| Europe Revenue Growth | -25.35% | +58.78% | -2.73% | +40.42% | +5.74% | -74.02% | -26.16% | n/a | n/a | n/a | n/a |
| North America Revenue | 69.56M | 64.52M | 37.28M | 44.68M | 35.6M | 40.6M | n/a | n/a | n/a | n/a | n/a |
| North America Revenue Growth | +7.81% | +73.09% | -16.57% | +25.52% | -12.32% | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Quarter | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 41.64M | 43.75M | 45.88M | 42.41M | 46M | 43.43M | 40.57M | 39.82M | 45M | 36.8M | 39.25M | 39.8M | 37.32M | 31.61M | 29.06M | 26.14M | 17.95M | 14.77M | 15.13M | 24.95M | 16.58M | 20.07M | 19.08M | 19.77M | 20.11M | 13.51M | 14.94M | 14.93M | 14.4M | 13.95M | 15.51M | 15.27M | 12.99M | 11.89M | 11.19M | 11.71M | 12.78M | 10.82M | 10.82M | 10.77M |
| Selling, General, and Administrative Revenue Growth | -4.81% | -4.65% | +8.19% | -7.81% | +5.91% | +7.04% | +1.90% | -11.52% | +22.31% | -6.26% | -1.39% | +6.66% | +18.08% | +8.76% | +11.17% | +45.60% | +21.53% | -2.35% | -39.36% | +50.50% | -17.39% | +5.15% | -3.46% | -1.69% | +48.87% | -9.62% | +0.06% | +3.73% | +3.19% | -10.02% | +1.57% | +17.49% | +9.24% | +6.27% | -4.41% | -8.36% | +18.10% | -0.03% | +0.45% | n/a |
| Research and Development Revenue | 27.47M | 25.52M | 38.48M | 43.45M | 44.54M | 47.51M | 46.17M | 48.94M | 42.62M | 47.09M | 50.35M | 52.94M | 42.58M | 27.51M | 22.27M | 20.55M | 17.43M | 16.47M | 15.01M | 15.25M | 14.27M | 14.96M | 14.91M | 15.48M | 16.26M | 14.36M | 15.66M | 16.31M | 15.63M | 15.84M | 16.88M | 16.97M | 16.25M | 17.48M | 17.52M | 16.36M | 14.75M | 16.16M | 15.04M | 14.48M |
| Research and Development Revenue Growth | +7.64% | -33.70% | -11.44% | -2.44% | -6.25% | +2.90% | -5.65% | +14.82% | -9.49% | -6.47% | -4.89% | +24.34% | +54.78% | +23.54% | +8.36% | +17.92% | +5.82% | +9.71% | -1.57% | +6.85% | -4.60% | +0.35% | -3.71% | -4.78% | +13.28% | -8.35% | -3.97% | +4.38% | -1.38% | -6.15% | -0.52% | +4.40% | -7.00% | -0.25% | +7.10% | +10.91% | -8.72% | +7.44% | +3.87% | n/a |